ArticleRSC advances2025
Development of a multi-source blue light irradiation platform for photometric quantification of ascorbic acid
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fluorescein spectrofluorometric quenching detection of chloride and iodide using eight-Blue-LEDs excitation and dual solar cells.Scientific reports · 2026Article
- A dual-angle optoelectronic flow injection platform for ferrous ion (FeRSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A novel and meticulously optimised continuous flow injection analysis (CFIA) protocol was developed for the spectrophotometric quantification of ascorbic acid using a locally engineered optical system. The detection unit incorporated eight blue light-emitting diodes (LEDs) arranged in a matrix geometry distributed across two angular regions: 0-90° and 0-180°, while dual solar cells served as photonic detectors. Spectral measurements were specifically conducted at 0-180°, yielding enhanced absorbance stability and signal quality. Based on a redox-induced quenching mechanism, the system utilises a chromogenic FeSCN
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.